Results

Total Results: 571 records

Showing results for "trend".

1. Slide 1 (ppt file)
   effectivehealthcare.ahrq.gov/sites/default/files/marketing_evidence_evans.ppt
   September 13, 2006 - 26.8% 25.3% 23.7% 22.0% 19.6% Actual Q2 99 - Q2 02 7.4% Year Actual trend Predicted Trend (truth ≠ … Trend in actual smoking 19.4% 19.1% 17.5% 14.6% 12.2% 10.7% Predicted trend if truth did not exist … 27.6% 25.7% 24.1% 21.8% 18.4% Actual Q2 99 - Q2 02 8.0% Year Actual trend Predicted Trend (truth ≠ … 35.1% 34.6% 32.9% 32.1% 29.7% Actual Q2 99 - Q2 02 7.9% Year Actual trend Predicted Trend (truth ≠ … 26.8% 25.3% 23.7% 22.0% 19.6% Actual Q2 99 - Q2 02 7.4% Year Actual trend Predicted Trend (truth ≠

2. Clinical-Care-Rapid-Review-Appendix-C (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/clinical-care-rapid-review-appendix-c.xlsx
   January 01, 2018 - 19.6 (SD 11.2) NA Comparator: Arm 1 Z-score: -6.4 (SE ), p<0.0001 Regression for difference in time trend … Time to closure, years 2000-2006 NR Mean: 4 (SD 1.3) NA Reference Regression for difference in time trend … between pre- and postintervention periods: 0.02 (SE 0.04), p=0.62 Regression for difference in time trend … 100,000 patient encounters 2006-2013 NR Mean: 5.1 (SD 3.3) NA Comparator: Arm 1 Difference in time trend … in monthly rates of lawsuits NR 498 claims NR NA Comparator: Arm 1 Difference in trend (pre vs post)

3. Data Points 17: Trends in Bariatric Surgery: Trends in bariatric surgery in Medicare beneficiaries (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/bariatric-surgery-trends_research.pdf
   November 01, 2012 - A similar trend was observed with ORYGB and DS (from 11.3% to 4.0% and 1.9% to 0.3%, respectively,

4. Partial Breast Irradiation for Breast Cancer: Systematic Review Protocol (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/pbi-protocol.pdf
   August 09, 2021 - theoretical study" or "theoretical analysis " or "feasibility study" or "feasibility analysis" or "trend … study" or "trend survey" or "trend analysis" or ((correlation* adj2 study) or (correlation* adj2 analys … study" or "trend survey" or "trend analysis" or ((correlation* W/2 study) or (correlation* W/2 analys … study” or “trend survey” or “trend analysis” or ((correlation* adj2 study) or (correlation* adj2 analys … study" or "trend survey" or "trend analysis" or ((correlation* W/2 study) or (correlation* W/2 analys

5. Trends in the use of echocardiography, 2007 to 2011 (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/echocardiography_research.pdf
   May 01, 2014 - Trends in the use of echocardiography, 2007 to 2011 Trends in the use of echocardiography, 2007 to 2011 Echocardiography Trends Data Points #20 Heart disease is the leading cause of death for men and women in the United States.1 In 2010, heart disease caused more than one in four, or 27 percent, of deaths among i…

6. Health-Careassociated-Infections Executive (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/health-careassociated-infections_executive.pdf
   November 01, 2012 - infection level) met selection criteria for this report and controlled for confounding or secular trend … strategies to improve adherence or infection rates and also controlled for confounding or secular trend … Four studies that did not adjust for confounding or secular trend provided information on the costs … This trend continued while the systematic review was being prepared. … Evidence Gaps Only one study, which did not control for confounding or secular trend, was found on

7. Cannabis-App-F5-Table-Surveillance-Report-2 0 0 (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f5-table-surveillance-report-2_0_0.xlsx
   May 29, 2025 - difference (95% CI) Level change after medical cannabis authorization: ˗183.2 (˗449.8 to 83.3) p=NS Trend … B Mean mg IV morphine (SD) 12.4 (20.1) vs. 12.3 (12.4); patient-month level trend analysis -0.64 (95%

8. Appendix-E-Table-E5 0 (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/Appendix-E-Table-E5_0.xlsx
   May 29, 2025 - difference (95% CI) Level change after medical cannabis authorization: ˗183.2 (˗449.8 to 83.3) p=NS Trend … B Mean mg IV morphine (SD) 12.4 (20.1) vs. 12.3 (12.4); patient-month level trend analysis -0.64 (95%

9. Mrsa-Screening-2010 Executive (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/mrsa-screening-2010_executive.pdf
   January 01, 2010 - ; non-CCS = studies not controlling for confounding and/or secular trend; PRISMA = Preferred Reporting … There was a statistically significant reduction in trend in incidence of MRSA acquisition (-0.045; … The Rodriguez-Bano study31 showed reductions in the incidence and trend of healthcare-associated MRSA … infection or colonization with expanded screening compared with limited screening (change in trend … Although the reduction in trend was statistically significant, the reduction in incidence was not.31

10. Stroke-Atrial-Fibrillation Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/stroke-atrial-fibrillation_executive.pdf
    August 01, 2013 - • Adding clopidogrel to warfarin shows a trend toward a benefit on stroke prevention (low strength … difference based on large RCT (HR 1.00; 95% CI 0.89 to 1.12), although a smaller study showed a trend … difference based on large RCT (HR 0.78; 95% CI 0.59 to 1.03), although a smaller study showed a trend … Warfarin Alone Ischemic stroke 1 (52,349) SOE = Low Trend toward benefit of warfarin + clopidogrel … RCT demonstrated benefit of rivaroxaban (HR 0.59; 95% CI 0.37 to 0.93); a smaller study showed a trend

11. Pharmacologic and Non-pharmacologic Therapies in Adult Patients with Acute Exacerbation of COPD: A Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/copd-research-protocol.pdf
    April 11, 2018 - prevention study/ 3403 81 exp replication study/ 1788 82 exp Feasibility Studies/ 154012 83 exp trend … replication analysis " or "replication trial" or "feasibility study" or "feasibility analysis" or "trend … study" or "trend survey" or "trend analysis" or ((correlation* adj2 study) or (correlation* adj2 analys … replication analysis " or "replication trial" or "feasibility study" or "feasibility analysis" or "trend … study" or "trend survey" or "trend analysis" or ((correlation* W/2 study) or (correlation* W/2 analys

12. Cer-250-Cannabis-Table-E5-2022-Update 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-table-e5-2022-update_0.xlsx
    January 01, 2022 - difference (95% CI) Level change after medical cannabis authorization: ˗183.2 (˗449.8 to 83.3) p=NS Trend … B Mean mg IV morphine (SD) 12.4 (20.1) vs. 12.3 (12.4); patient-month level trend analysis -0.64 (95%

13. Diabetes-Drugs-Utilization Research (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-drugs-utilization_research.pdf
    March 01, 2011 - This trend was consistent among all age groups. … percent (2009) had a claim for a thiazoli- dinedione, the latter representing a considerable decreasing trend … percent (2009) had a claim for a thiazolidinedione, the latter representing a considerable decreasing trend

14. Data Points #20: Echocardiography Trends | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/echocardiography/research

15. Radiotherapy-Proton-Beam Research (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/radiotherapy-proton-beam_research.pdf
    May 01, 2012 - comparative effectiveness or harms of this therapy.2 Financial factors may in part be driving this trend … Several factors likely explain the trend toward using proton beam therapy for prostate cancer. … Even a minimal trend toward proton therapy in prostate cancer treatment is likely to be widely felt

16. Cannabis-2022-Surv-Rep-3-Table-F5 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-table-F5.xlsx
    January 01, 2022 - difference (95% CI) Level change after medical cannabis authorization: ˗183.2 (95% CI ˗449.8 to 83.3) p=NS Trend … B Mean mg IV morphine (SD) 12.4 (20.1) vs. 12.3 (12.4); patient-month level trend analysis -0.64 (95%

17. Cannabis-2022-Update-Surv-Rep-1-App-F-5 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F-5.xlsx
    January 01, 2022 - difference (95% CI) Level change after medical cannabis authorization: ˗183.2 (95% CI ˗449.8 to 83.3) p=NS Trend … B Mean mg IV morphine (SD) 12.4 (20.1) vs. 12.3 (12.4); patient-month level trend analysis -0.64 (95%

18. Disposition of Comments for Screening of Methicillin-Resistant Staphylococcus Aureus (MRSA) (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/mrsa-screening-2010_disposition-comments.pdf
    January 01, 2010 - of MRSA infection with screening, though that decrease may actually be attributable to a secular trend … While the Huang study tested for trend and for autocorrelation, it did not control for any confounders … Both trend and level are important in interpreting the results of this study. … Though the reduction in trend was statistically significant (change in trend after the third intervention … I have been under the impression that when study after study yields the same finding or trend, that

19. Erythropoiesis-Stimulating-Agents-Utilization Research (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/erythropoiesis-stimulating-agents-utilization_research.pdf
    February 01, 2011 - Trends in the utilization of erythropoiesis-stimulating agents among Medicare beneficiaries with kidney disease Erythropoietins Data Points #4 The findings described herein were presented by Thomas MaCurdy, Ph.D., at the Medicare Evidence Development & Coverage Advisory Committee meeting held on March 24, 2010,…

20. 04-E029-1 Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-surveillance_executive.pdf
    December 01, 2011 - -based databases of patients with prostate cancer with time-trend data (reporting changes over a range … Time- trend data for Key Question 1 were graphed over the interval of interest (1980–2010). … studies that evaluated the distribution of patients’ ages into discrete categories generally supported a trend … A similar trend was observed in a study based on the SEER-New Mexico registry. … Another consistent trend in SEER data has been the decrease in low-grade (Gleason score 2–4) and high